Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Cooper

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|April 14, 2026
Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 DiseaseEwa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2011
Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous systemAhad A Rahim, Andrew M S Wong, Klemens Hoefer, et al.
Biochemical Society Transactions|December 2, 2010
In utero gene transfer to the mouse nervous systemAhad A Rahim, Andrew M S Wong, Suzanne M K Buckley, et al.
The Journal of Clinical Investigation|April 27, 2023
Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse modelKeigo Takahashi, Elizabeth M Eultgen, Sophie H Wang, et al.
Human Molecular Genetics|July 31, 2009
Molecular correlates of axonal and synaptic pathology in mouse models of Batten diseaseCatherine Kielar, Thomas M Wishart, Alice Palmer, et al.
Human Gene Therapy|December 31, 2013
Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 geneDolan Sondhi, Emma C Scott, Alvin Chen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinaseSashi Kesavapany, Kwok-Fai Lau, Steven Ackerley, et al.
Brain Research|July 10, 2007
Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosisJill M Weimer, Jared W Benedict, Yasser M Elshatory, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|May 21, 2011
Insulin receptor substrate 2 is a negative regulator of memory formationElaine E Irvine, Laura Drinkwater, Kasia Radwanska, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2014
An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosisShannon L Macauley, Andrew M S Wong, Charles Shyng, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|April 14, 2026
Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 DiseaseEwa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2011
Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous systemAhad A Rahim, Andrew M S Wong, Klemens Hoefer, et al.
Biochemical Society Transactions|December 2, 2010
In utero gene transfer to the mouse nervous systemAhad A Rahim, Andrew M S Wong, Suzanne M K Buckley, et al.
The Journal of Clinical Investigation|April 27, 2023
Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse modelKeigo Takahashi, Elizabeth M Eultgen, Sophie H Wang, et al.
Human Molecular Genetics|July 31, 2009
Molecular correlates of axonal and synaptic pathology in mouse models of Batten diseaseCatherine Kielar, Thomas M Wishart, Alice Palmer, et al.
Human Gene Therapy|December 31, 2013
Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 geneDolan Sondhi, Emma C Scott, Alvin Chen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinaseSashi Kesavapany, Kwok-Fai Lau, Steven Ackerley, et al.
Brain Research|July 10, 2007
Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosisJill M Weimer, Jared W Benedict, Yasser M Elshatory, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|May 21, 2011
Insulin receptor substrate 2 is a negative regulator of memory formationElaine E Irvine, Laura Drinkwater, Kasia Radwanska, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2014
An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosisShannon L Macauley, Andrew M S Wong, Charles Shyng, et al.
Pageof 15